HighQC™ Human Brain Cancer Stem Cell
HighQC™ Human Brain Cancer Stem Cells are isolated from primary human glioblastoma tissues and enriched for tumor-initiating cells using markers such as CD133, CD44, CD34, SSEA 3/4, Oct4, confirmed by flow cytometry. These cells exhibit characteristic stem-like morphology with small, round shapes and the ability to form neurospheres in vitro. They possess self-renewal and multipotent differentiation capabilities, giving rise to heterogeneous tumor cell populations including neurons, astrocytes, and oligodendrocyte-like cells. These brain cancer stem cells (BCSCs) are critical for studying glioma initiation, progression, therapeutic resistance, and recurrence. Each lot undergoes rigorous screening and isolation procedures, and is rigorously tested to ensure it is free of contamination from HIV-1, HBV, HCV, syphilis, mycoplasma, fungi, yeast, and bacteria.